Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday. Pfizer's offer for the San Francisco-based Medivation goes far beyond the company's market value of $11.1 billion. The boards of directors of both companies have unanimously approved the merger, the statement said. "The proposed acquisition of Medivation is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Pfizer," said Ian Read, Pfizer chairman and chief executive officer. |
|
GMT 13:29 2018 Friday ,14 December
Turkey targets military over alleged Gulen linksGMT 09:32 2018 Wednesday ,12 December
Huawei CFO gets bail; China detains ex-Canadian diplomatGMT 09:24 2018 Wednesday ,12 December
LuLu supports KFUPM Rectors Cup marathonGMT 09:12 2018 Wednesday ,12 December
Ford trains 1,600 motorists in Mideast, Africa in 2018GMT 09:00 2018 Wednesday ,12 December
May tours Europe in desperate bid to save Brexit dealGMT 08:25 2018 Wednesday ,12 December
Australian government discusses moving Israel embassy to JerusalemGMT 10:32 2018 Tuesday ,11 December
Trump’s troubled White House in search of new chief of staffGMT 10:03 2018 Monday ,10 December
23 Palestinians arrested in West BankMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor